vs
Side-by-side financial comparison of HARROW, INC. (HROW) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $89.1M, roughly 1.4× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 1.5%, a 5.9% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -4.8%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
HROW vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $124.7M |
| Net Profit | $6.6M | $1.9M |
| Gross Margin | 79.3% | 24.3% |
| Operating Margin | 17.5% | 3.3% |
| Net Margin | 7.4% | 1.5% |
| Revenue YoY | 33.3% | -3.9% |
| Net Profit YoY | -2.2% | -53.6% |
| EPS (diluted) | $0.20 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $124.7M | ||
| Q3 25 | $71.6M | $85.1M | ||
| Q2 25 | $63.7M | $140.8M | ||
| Q1 25 | $47.8M | $115.9M | ||
| Q4 24 | $66.8M | $129.7M | ||
| Q3 24 | $49.3M | $88.3M | ||
| Q2 24 | $48.9M | $159.1M | ||
| Q1 24 | $34.6M | $137.5M |
| Q4 25 | $6.6M | $1.9M | ||
| Q3 25 | $1.0M | $-3.4M | ||
| Q2 25 | $5.0M | $8.6M | ||
| Q1 25 | $-17.8M | $2.1M | ||
| Q4 24 | $6.8M | $4.5M | ||
| Q3 24 | $-4.2M | $-1.9M | ||
| Q2 24 | $-6.5M | $27.9M | ||
| Q1 24 | $-13.6M | $7.9M |
| Q4 25 | 79.3% | 24.3% | ||
| Q3 25 | 75.3% | 25.9% | ||
| Q2 25 | 74.5% | 28.8% | ||
| Q1 25 | 67.5% | 24.1% | ||
| Q4 24 | 78.8% | 26.6% | ||
| Q3 24 | 75.6% | 27.4% | ||
| Q2 24 | 74.4% | 35.5% | ||
| Q1 24 | 69.5% | 28.7% |
| Q4 25 | 17.5% | 3.3% | ||
| Q3 25 | 20.6% | -3.5% | ||
| Q2 25 | 17.9% | 9.3% | ||
| Q1 25 | -23.5% | 4.1% | ||
| Q4 24 | 19.3% | 5.8% | ||
| Q3 24 | 2.7% | -1.7% | ||
| Q2 24 | 3.1% | 17.4% | ||
| Q1 24 | -20.0% | 8.2% |
| Q4 25 | 7.4% | 1.5% | ||
| Q3 25 | 1.4% | -4.0% | ||
| Q2 25 | 7.8% | 6.1% | ||
| Q1 25 | -37.2% | 1.8% | ||
| Q4 24 | 10.1% | 3.5% | ||
| Q3 24 | -8.6% | -2.1% | ||
| Q2 24 | -13.2% | 17.5% | ||
| Q1 24 | -39.2% | 5.7% |
| Q4 25 | $0.20 | $0.04 | ||
| Q3 25 | $0.03 | $-0.08 | ||
| Q2 25 | $0.13 | $0.19 | ||
| Q1 25 | $-0.50 | $0.05 | ||
| Q4 24 | $0.19 | $0.10 | ||
| Q3 24 | $-0.12 | $-0.04 | ||
| Q2 24 | $-0.18 | $0.60 | ||
| Q1 24 | $-0.38 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $22.4M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $363.2M |
| Total Assets | $399.5M | $548.6M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $22.4M | ||
| Q3 25 | $74.3M | $18.0M | ||
| Q2 25 | $53.0M | $25.2M | ||
| Q1 25 | $66.7M | $26.7M | ||
| Q4 24 | $47.2M | $39.1M | ||
| Q3 24 | $72.6M | $35.5M | ||
| Q2 24 | $71.0M | $60.8M | ||
| Q1 24 | $76.0M | $47.4M |
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $363.2M | ||
| Q3 25 | $47.0M | $364.4M | ||
| Q2 25 | $49.7M | $372.5M | ||
| Q1 25 | $56.5M | $366.9M | ||
| Q4 24 | $69.7M | $371.5M | ||
| Q3 24 | $58.0M | $380.0M | ||
| Q2 24 | $58.5M | $399.9M | ||
| Q1 24 | $60.6M | $376.4M |
| Q4 25 | $399.5M | $548.6M | ||
| Q3 25 | $363.1M | $554.6M | ||
| Q2 25 | $345.0M | $559.6M | ||
| Q1 25 | $364.2M | $578.9M | ||
| Q4 24 | $389.0M | $587.4M | ||
| Q3 24 | $351.5M | $571.3M | ||
| Q2 24 | $306.6M | $577.4M | ||
| Q1 24 | $295.5M | $570.6M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $27.3M |
| Free Cash FlowOCF − Capex | $8.1M | $16.3M |
| FCF MarginFCF / Revenue | 9.1% | 13.1% |
| Capex IntensityCapex / Revenue | 0.4% | 8.8% |
| Cash ConversionOCF / Net Profit | 1.27× | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $27.3M | ||
| Q3 25 | $16.6M | $-8.1M | ||
| Q2 25 | $-803.0K | $40.8M | ||
| Q1 25 | $19.7M | $-9.8M | ||
| Q4 24 | $-17.8M | $-7.4M | ||
| Q3 24 | $3.0M | $-30.8M | ||
| Q2 24 | $-2.7M | $43.7M | ||
| Q1 24 | $-4.6M | $25.2M |
| Q4 25 | $8.1M | $16.3M | ||
| Q3 25 | $16.4M | $-12.4M | ||
| Q2 25 | $-969.0K | $33.5M | ||
| Q1 25 | $19.5M | $-16.1M | ||
| Q4 24 | $-18.3M | $-10.7M | ||
| Q3 24 | $2.3M | $-35.5M | ||
| Q2 24 | $-3.1M | $38.2M | ||
| Q1 24 | $-4.7M | $7.0M |
| Q4 25 | 9.1% | 13.1% | ||
| Q3 25 | 22.9% | -14.6% | ||
| Q2 25 | -1.5% | 23.8% | ||
| Q1 25 | 40.8% | -13.9% | ||
| Q4 24 | -27.4% | -8.3% | ||
| Q3 24 | 4.8% | -40.2% | ||
| Q2 24 | -6.3% | 24.0% | ||
| Q1 24 | -13.6% | 5.1% |
| Q4 25 | 0.4% | 8.8% | ||
| Q3 25 | 0.3% | 5.0% | ||
| Q2 25 | 0.3% | 5.2% | ||
| Q1 25 | 0.4% | 5.4% | ||
| Q4 24 | 0.8% | 2.5% | ||
| Q3 24 | 1.2% | 5.3% | ||
| Q2 24 | 0.7% | 3.5% | ||
| Q1 24 | 0.3% | 13.2% |
| Q4 25 | 1.27× | 14.22× | ||
| Q3 25 | 16.26× | — | ||
| Q2 25 | -0.16× | 4.73× | ||
| Q1 25 | — | -4.68× | ||
| Q4 24 | -2.62× | -1.63× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
